H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.
about
Targeting Angiogenesis in Biliary Tract Cancers: An Open OptionmiR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes.Recent advances in the regulation of cholangiocarcinoma growthNeuropeptide Y inhibits cholangiocarcinoma cell growth and invasion.Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growthCastration inhibits biliary proliferation induced by bile duct obstruction: novel role for the autocrine trophic effect of testosterone.Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinomaInhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition.Differential function and regulation of orphan nuclear receptor TR3 isoforms in endothelial cells.Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases.Histamine regulation of pancreatitis and pancreatic cancer: a review of recent findings.Vascular factors, angiogenesis and biliary tract diseaseHistamine and histamine receptor regulation of gastrointestinal cancers.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.C-kit mutations and PKC crosstalks: PKC translocates to nucleous only in cells HMC⁵⁶⁰,⁸¹⁶.Agonist-induced activation of histamine H3 receptor signals to extracellular signal-regulated kinases 1 and 2 through PKC-, PLD-, and EGFR-dependent mechanisms.Lipid Storage and Autophagy in Melanoma Cancer Cells.Histamine regulation of biliary proliferation.Cholangiocarcinoma pathogenesis: Role of the tumor microenvironment.Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms.Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.Knockout of histidine decarboxylase decreases bile duct ligation-induced biliary hyperplasia via downregulation of the histidine decarboxylase/VEGF axis through PKA-ERK1/2 signaling.Reactive Ductules Are Associated With Angiogenesis and Tumor Cell Proliferation in Pediatric Liver CancerBlocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 mice and human cholangiocarcinoma tumorigenesisMolecular pathogenesis of cholangiocarcinoma
P2860
Q30398807-D012CB32-31A2-4ECF-9DA0-560F96F96F13Q30760000-876BD802-25A8-464C-95DA-742F9DC9F436Q33909909-5400B433-57D9-40B2-A603-74B65FA53ABBQ33994814-4BE70F58-F16D-473C-804D-AE0BE9F700F9Q34979300-1A19BE1C-7CD8-4684-8DD7-154013620B85Q35321923-D1DF6C19-9025-441F-A2DB-699E41EDE20CQ35601290-56A11427-CED4-43CF-A62B-8F6E1F5E7422Q35629462-F9B0C788-2EC2-4E70-AABC-F02B501F2BACQ36231984-15D59CA5-54B3-4BF6-9CAF-E007B4B5E3AEQ36814082-2393D7D7-5572-4A8E-99D0-9464254AC8A5Q37028411-4FE0B478-F5AE-464D-9E25-B9CDB92B7D46Q37584658-494B06E5-A19C-40AE-815C-6267D0332187Q37584702-B75FCF63-85E4-4C0F-B150-D37585456434Q37671557-0BB68F3A-91CA-4509-A2ED-D6A67103C5DBQ38196813-D01E51BC-1249-4677-A0C4-F392D3529D50Q38812588-DAB633E9-CC4F-4022-BEEF-316560375F26Q39017962-6A3D6AA8-C25D-4416-8A6B-73772E9E8D43Q39500168-FF4526FA-4E7D-41A9-B896-39861595CFABQ39539308-3D577F9E-FAFE-4B5F-9B0A-66D445111C13Q40041186-FF174320-EA36-40BD-9DCD-F2DE9CC426F2Q41033721-5FB7A25A-B901-47BD-B52B-BA503E6B30C0Q41767337-507DFE32-7795-450F-B9A1-B490D56BB031Q42029380-0B5D8B69-1635-43C8-A2E9-94EAB7816E4CQ42045559-BC752F22-3A93-40B8-AC5A-E408D3BBFD9FQ47099304-0F61B4F3-B710-43D7-93D8-E65E9496392DQ48223400-0030D2DB-CD60-4154-A65E-F9C231A25783Q57069778-65C372FC-BD93-414E-A091-92004F664711Q57121405-A51B2F51-1869-486A-B440-E1E23DBD1D64Q58704494-082D719B-9CA4-4AD4-A1FC-235DEC129294
P2860
H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
H3 histamine receptor-mediated ...... arcinoma in vitro and in vivo.
@en
H3 histamine receptor-mediated ...... arcinoma in vitro and in vivo.
@nl
type
label
H3 histamine receptor-mediated ...... arcinoma in vitro and in vivo.
@en
H3 histamine receptor-mediated ...... arcinoma in vitro and in vivo.
@nl
prefLabel
H3 histamine receptor-mediated ...... arcinoma in vitro and in vivo.
@en
H3 histamine receptor-mediated ...... arcinoma in vitro and in vivo.
@nl
P2093
P2860
P50
P1476
H3 histamine receptor-mediated ...... carcinoma in vitro and in vivo
@en
P2093
Antonella Vetuschi
Eugenio Gaudio
Fanyin Meng
Gianfranco Alpini
Heather Francis
Julie Venter
Mellanie White
Roberta Sferra
Sharon DeMorrow
Shelley Kopriva
P2860
P304
P356
10.1158/1541-7786.MCR-09-0261
P577
2009-10-13T00:00:00Z